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Abstract. Deep learning (DL) networks have recently been shown to
outperform other segmentation methods on various public, medical-image
challenge datasets [3,11,16], especially for large pathologies. However, in
the context of diseases such as Multiple Sclerosis (MS), monitoring all the
focal lesions visible on MRI sequences, even very small ones, is essential
for disease staging, prognosis, and evaluating treatment efficacy. More-
over, producing deterministic outputs hinders DL adoption into clinical
routines. Uncertainty estimates for the predictions would permit subse-
quent revision by clinicians. We present the first exploration of multiple
uncertainty estimates based on Monte Carlo (MC) dropout [4] in the con-
text of deep networks for lesion detection and segmentation in medical
images. Specifically, we develop a 3D MS lesion segmentation CNN, aug-
mented to provide four different voxel-based uncertainty measures based
on MC dropout. We train the network on a proprietary, large-scale, multi-
site, multi-scanner, clinical MS dataset, and compute lesion-wise uncer-
tainties by accumulating evidence from voxel-wise uncertainties within
detected lesions. We analyze the performance of voxel-based segmenta-
tion and lesion-level detection by choosing operating points based on
the uncertainty. Empirical evidence suggests that uncertainty measures
consistently allow us to choose superior operating points compared only
using the network’s sigmoid output as a probability.
Keywords: uncertainty, segmentation, detection, Multiple Sclerosis
1 Introduction
Deep learning (DL) has become ubiquitous in computer vision and other ap-
plications [7,13], yet its adoption in medical imaging has been comparatively
slow, due, in part, to the shortage of large-scale annotated datasets. Recently,
DL frameworks have been shown to outperform other segmentation methods on
a variety of public challenge datasets [3,11,16], particularly on metrics focused
on large pathologies. For neurological diseases such as Multiple Sclerosis (MS),
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lesions can be very small (eg. 3-5 voxels) and the detection and segmentation of
lesions of all sizes on MRI sequences is a key component for clinical assessment
of disease stage and prognosis, as well as for evaluating the efficacy of treatments
during clinical trials. Early DL approaches have shown success in the segmenta-
tion of large lesions [2], and recent work has shown how using a tissue-prior or
lesion-prior can improve detection for medium and small lesions on small, private
datasets [6]. However, current DL methods have not yet been shown to outper-
form other machine learning methods in the detection of small lesions, leading
to potential errors in patient lesion counts, which may have serious consequences
in clinical trials. Moreover, DL methods typically produce predictors with deter-
ministic outcomes. In contrast, traditional Bayesian machine learning provides
not only a prediction, but also an uncertainty about it, through a probability
density over outcomes. While mathematically principled, traditional Bayesian
approaches to DL have not been widely used in applications due to implementa-
tion challenges and excessive training times. Recently, Gal and Ghahramani [4]
presented a simpler approach to uncertainty estimation for DL, by training a
dropout network and taking Monte Carlo (MC) samples of the prediction using
dropout at test time. This approach produces an approximation of the posterior
of the network’s weights. In computer vision, modeling uncertainty improves the
performance of a standard scene understanding network with no additional pa-
rameterization [9]. In the first application to medical image analysis, [17], add
uncertainty modelling in a CNN to achieve state-of-the-art performance on the
super-resolution of diffusion MR brain images, providing a discussion of how
the predictive variance and MC sample variance uncertainties lead to this im-
provement. In [12], the authors leverage MC sample variance in a two-stage lung
nodule detection system where they rely on uncertainty at nodule contours, and
an initial prediction into the second stage, without an analysis of the usefulness
of the uncertainty measure. In [10], the authors perform an evaluation of the
MC sample variance for image-based diabetic retinopathy diagnosis. They show
that the sample variance is useful for referring cases to experts in this context.
We present the first qualitative and quantitative comparison of the effective-
ness of several different uncertainty measures derived from MC dropout in the
context of DL for lesion segmentation and detection in medical images. We de-
velop a 3D MS lesion segmentation CNN, augmented to provide four voxel-based
uncertainty measures based on MC dropout: predictive variance, MC sample
variance, predictive entropy, and mutual information. The network is trained on
a large proprietary, multi-scanner, multi-center, clinical trial dataset of patients
with Relapsing-Remitting MS (RRMS). Voxel-wise uncertainties are combined
to estimate lesion-level uncertainties. The resulting voxel-based segmentation
and lesion-level detection performance are examined when choosing operating
points on ROC curves (TPR vs. FDR) based on thresholded uncertainty levels.
Our results indicate that while bigger lesions have large voxel-based uncertain-
ties primarily along the border, the smallest lesions have the highest lesion-level
detection errors, along with the highest uncertainty. Selecting operating points
based on dropout uncertainty measures proves to be a more robust and princi-
pled approach than typical thresholding based on the network’s sigmoid output.
2 Proposed Method
We develop a 3D fully convolutional neural network (CNN) with dropout to seg-
ment lesions from MRI sequences, by providing binary labels (lesion/non-lesion)
to all voxels. The network is simultaneously trained to estimate uncertainty, as
we will describe in detail below. Figure 1 contains the flowchart of our method.
During testing, we pass an unseen multi-modal MR volume, x∗, through the
network T times to obtain MC samples and estimate the uncertainty. The mean
of the sample segmentations is used to obtain a single prediction.
Fig. 1. Network architecture. All convolutional operations are 3D and we use additive
skip connections instead of concatenating ones to reduce the number of parameters
2.1 Dropout as a Bayesian Approximation
During training, pairs of multi-sequence 3D MRIs,X, and their associated binary
ground truth T2 lesion labels, Y, are used to learn the weights, W , of the 3D
CNN. To capture uncertainty in the model, a prior distribution is placed overW ,
and an estimate of the posterior p(W |X,Y) is computed. Although computing
this posterior analytically is intractable, variational methods can approximate it
with a parameterized distribution q(W ) which minimizes the Kullback-Leibler
(KL) divergence [1]:
q∗(W ) = argmin
q(W )
KL(q(W ) || p(W |X,Y)). (1)
In [4], the authors show that minimizing the cross-entropy loss of a network with
dropout applied after each layer of weights is equivalent to the minimization of
the KL-divergence in Eq. (1), where the approximating distribution, q(W ), is a
mixture of two Gaussians: N (0, I) and N (M, I) with small variances , mixing
coefficients p and 1−p respectively, and whereM are the variational parameters
for weights W . Their derivation treats sampling from the mixture of Gaussians
as sampling from a Bernoulli random variable returning either 0 orM , and links
this to the application of dropout in a deep network. This is a key result, and
means that we can sample from a dropout network’s outputs to approximate the
posterior p(Yˆ |X∗,W ) over the lesion label prediction Yˆ for an input MRI X∗.
2.2 Measures of Uncertainty in DL Networks
We now describe the four uncertainty measures we will compute: prediction
variance, which is learned directly from the training data and was discussed
in [4], and three stochastic sampling-based measure based on dropout: variance
of MC samples, predictive entropy, and mutual information.
Prediction Variance During training, in addition the labels, the weights of
the network are also trained to produce the prediction variance Vˆ at the output
(Figure 1). DL networks for classification typically pass network outputs, FW ,
through a sigmoid or softmax function to obtain predictions Yˆ ∈ [0, 1], which
are then used in a loss function that compares them against ground truth labels
Y . In our model, we follow the approach of [8], and assume the network outputs
are corrupted by Gaussian noise with mean 0, and variance V at every voxel.
The network is trained to output an estimate, VˆW , of the noise variance by
reformulating prediction YˆW as:
YˆW = sigmoid(FW +N (0, IVˆW )). (2)
During training, the Gaussian distribution is integrated out by taking T MC
samples of YˆW and VˆW . We then use the standard weighted, binary cross-entropy
function, averaging across the MC samples. Because the prediction variance is
used to compute segmentations Yˆ , and subsequently the cross-entropy loss, the
weight updates to the network during backpropagation push the network to learn
the variance estimates without having explicit labels for them.
MC Sample Variance As in previous work applying MC dropout meth-
ods [9,10,17,12], the MC sample variance is a measure of uncertainty derived from
the variance of the T MC samples of the predicted segmentation, var(Yˆ1, ..., YˆT ).
Predictive Entropy The predictive entropy is a measure of how much informa-
tion is in the model predictive density function at each voxel i. We approximate
the entropy for an input voxel x∗i across T MC samples and C classes with the
following biased estimator [5]:
H[yˆi|x∗i ,X,Y] ≈ −
C∑
c=1
1
T
T∑
t=1
p(yˆi = c|x∗i ,Wt)log(
1
T
T∑
t=1
p(yˆi = c|x∗i ,Wt)). (3)
Mutual Information Finally, the mutual information between the model pos-
terior density function and the prediction density function is approximated at
each voxel i as the difference between the entropy of the expected prediction,
and the expectation of the model prediction entropies across samples [5]:
MI[yˆi,W |x∗i ,X,Y] ≈ H[yˆi|x∗i ,X,Y]− E[H[yˆi|x∗i ,W ]]. (4)
2.3 Uncertainty-based Filtering in Lesion Segmentation/Detection
The network outputs yˆi computed as in Eq.(2) as well as the four defined mea-
sures of uncertainty Um(i), i = 1 . . . 4 at every voxel x∗i . The standard approach
to generate a classification would be to compute the indicator function 1yˆi≥θ
where the threshold θ is specified (eg. 0.9). When we use the uncertainty mea-
sure, we will additionally require that Um(i) is below another chosen threshold
η in order to produce the prediction. If the predictions that are incorrect are un-
certain, this filtering should increase the performance on remaining predictions.
In the context of neurological diseases such as MS, it important to perform
lesion-level detection because changes in the a patient’s lesion count are in-
dicative of disease activity and progression. This requires a strategy to merge
voxel-level uncertainty measures into lesion-level uncertainty, which is then used
to perform lesion-wise filtering. Suppose we can generate a large set of candidate
lesions. For a candidate l, composed of voxels p, ..., q, we will compute the lesion-
uncertainty Um(l) from the voxel-wise uncertainties as: Um(l) =
∑q
i=p log(Um(i)).
Taking the log-sum of the voxel-level uncertainties reflects the simplifying as-
sumption that neighbouring voxels are conditionally independent, given that
they are part of l. To make the uncertainties comparable through a single
threshold value, we rescale the values Um(l) to [0, 1] by subtracting by the min-
imum lesion uncertainty and dividing by the range; we do this separately for
each measure m. Detection is then performed using the uncertainty threshold
and outputs in the same case as for the voxel-level. Further implementation
details can be found in the supplementary material and code is available at
https://github.com/tanyanair/segmentation_uncertainty.
3 Experiments and Results
The method was evaluated on a proprietary, multi-site, multi-scanner, clinical
trial dataset of 1064 Relapsing-Remitting MS (RRMS) patients, scanned annu-
ally over a 24-month period. T1, T2, FLAIR, and PDW MRI sequences were
acquired at a 1mm x 1mm x 3mm resolution and pre-processed with brain ex-
traction [15], N3 bias field inhomogeneity correction [14], Nyul image intensity
normalization, and registration to the MNI-space. Ground truth T2 lesion seg-
mentation masks were provided with the data. These were obtained using a
proprietary approach where the result of an automated segmentation method
was manually corrected by expert human annotators. The network was trained
on 80% of the subjects, with 10% held out for validation and 10% for testing
(2182/251/251 scans for training/validation/testing respectively). We take 10
MC samples during training and testing for the evaluation of the uncertainties.
To see if the uncertainty measures are useful and describe different informa-
tion, we plot the voxel-level True Positive Rate (TPR = TPTP+FN ), and False
Detection Rate (FDR = 1− TPTP+FP ) Receiver Operating Characteristic (ROC)
curves for the retained voxels at different uncertainty thresholds, and them com-
pare against a baseline ROC in which no uncertainty thresholding is performed
(Fig. 2a). At operating points of interest (FDR < 0.3), different measures lead
to different percentage levels of voxel retention. The notably high TPR of the
predicted variance curve can be attributed to the significantly lower voxel-level
retention.
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(b) lesion-wise thresholding across (left to right): all, small, medium, and large lesions
Fig. 2. FDR vs. TPR of retained predictions when (a) voxel-wise thresholding with
each uncertainty measure and (b) lesion-wise thresholding with the entropy measure. In
(a) the % of voxels retained is provided with each uncertainty measure in the legend.
In (b), the % of lesions retained for each curve’s uncertainty threshold is provided
in the color coded legend for that plot. The uncertainty threshold used to generate
a given color’s curve in a plot is the same across these plots. Points along a curve
correspond to different sigmoid thresholds used to binarize the model’s segmentation
output. Each plot contains a reference curve (100%) corresponding to the model’s
baseline performance when no uncertainty thresholding is performed.
To obtain lesion-level statistics from voxel segmentations, ground truth le-
sions smaller than 3 voxels were removed, as per clinical protocol. We performed
voxel-level classification and candidate lesions are then obtained from lesion vox-
els by considering a surrounding, 18-connected neighbourhood in order to miti-
gate the impact of under-segmented ground truth in this dataset. A true positive
(TP) lesion is detected when the segmentation, including its 18-connected neigh-
bourhood, overlaps with at least three, or more than 50%, of the ground truth
lesion voxels. Insufficient overlap results in a false negative (FN), and candidate
lesions of 3 or more voxels that do not overlap with a ground truth lesion are
counted as false positives (FP). Lesion-level TPR, and FDR ROC curves for re-
tained predictions at different entropy thresholds are shown in Fig. 2b. Results
for the other measures can be found in the supplementary material, as they were
extremely similar to one another. At all operating points, across all measures,
using uncertainty to exclude uncertain predictions improves performance on re-
maining predictions, even when excluding just 2% of the most uncertain lesions,
due to the resulting reduction in the number of both FP and FN assertions. In an
analysis across small (3-10 vox), medium (11-50 vox), and large (51+) lesion bin
sizes (Fig. 2b), we find that using uncertainty to exclude predictions is helpful
for small lesions regardless of the exact uncertainty measure used. This is be-
cause the model does not perform as well for small lesions, which constitute 40%
of lesions in the dataset, so removing the uncertain FP and FN segmentations
improves the overall performance. However, for medium and large lesions, per-
formance reduces slightly compared to non-thresholded segmentations because
the DL model has very few FP’s and FN’s for medium and large lesions. Filtering
out these sized lesions reduces TP’s, reducing the performance for those sizes.
Fig. 3(e-h) provides an example of uncertainties themselves. In general, mea-
sures computed from stochastic dropout samples are more uncertain around
lesion contours. Relative to other work [12,17], the MC sample variance is very
small, even around lesion contours, but mutual information and predictive en-
tropy reflect the boundary-uncertainty more intensely. The learned, predictive
variance reflects data uncertainty throughout contours in the entire MRI (e.g.
boundaries between white matter and grey matter). Despite these voxel-wise
differences, when accumulating evidence to the lesion-level, the different mea-
sures tend to rank lesions is the same order of certainty, albeit on different
scales, which leads to filtering out the same lesions, at different thresholds (ie.
Fig. 3c-d)). One interpretation is that between taking MC dropout samples, and
computing the uncertainty measures, no new information is added. We also note
that small lesions are relatively more uncertain than medium and large lesions.
This is a consequence of computing lesion uncertainty from the log sum of all the
uncertainty values in a detected lesion area. Although large lesions have larger,
more uncertain contours, the accumulation of lesion-evidence within the bound-
ary provides an overwhelming certainty that there is a lesion there. This is not
the case for small lesions (less evidence).
4 Conclusion
We developed a 3D MS lesion segmentation CNN, augmented to provide four
voxel-based uncertainties, and showed how these can be accumulated to estimate
lesion-level uncertainties. Our results indicate that filtering based on uncertainty
greatly improves lesion detection accuracy for small lesions, which make up 40%
of the dataset, indicating that high uncertainty does indeed reflect incorrect
predictions. Moreover, uncertainty measures in the results of an automatic, DL
detection or segmentation method provide clinicians or radiologists with infor-
Fig. 3. Visualization of a single MR slice’s segmentation for different uncertainty
thresholds. From top to bottom we use the following uncertainty measures: entropy,
mutual information, MC sample variance, and predicted variance. From left to right
we show i. Baseline (no uncertainty thresholding) lesion segmentation. ii., iii. Seg-
mentation at two different thresholds for the uncertainty corresponding to that row
(ie. more lesions are excluded in iii.). Lesions are coloured with the following scheme:
TP: green, FP:red, FN: blue, and True Negative (TN): white. Lesions a, d show the
uncertainty corresponding to a FP in the baseline segmentation turned into a TN as
the uncertainty threshold is increased. b, c show a TP (from another slice) becoming
a FN. d shows a FP (from another slice) becoming a TN. The lesion uncertainties at d
are shown for e entropy, f mutual information, g MC sample variance, and h predicted
variance. Note that the threshold to turn lesions into TN’s or FN’s is different for
different uncertainty measures. All MRI are courtesy of Neurorx Research.
mation permitting them to quickly assess whether to accept or reject lesions of
high uncertainty, for example, or further analyze uncertain lesion boundaries.
This could facilitate the wider adoption of DL methods into clinical work-flows.
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